JANNEY DANIEL
SEC Form 4 insider trading activity
JANNEY DANIEL has filed 2 SEC Form 4 filings (23 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Mar 3, 2026.
On the most recent filing, JANNEY DANIEL is listed as Director at Krystal Biotech, Inc. Inside the rolling window, JANNEY DANIEL reported no open-market purchases and 4 open-market sales totaling $19.4M in KRYS. The largest disclosed transaction in the window is a sale of 51,720 KRYS shares on Feb 24, 2026, worth $13.8M.
Companies traded
Other insiders at KRYS
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$19.4M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has JANNEY DANIEL made?
JANNEY DANIEL has filed 2 SEC Form 4 filings (23 transaction rows) across 1 company since 2026.
Which companies does JANNEY DANIEL trade?
JANNEY DANIEL has filed SEC Form 4 disclosures for 1 company, including KRYS.
When was JANNEY DANIEL's most recent SEC Form 4 filing?
JANNEY DANIEL's most recent SEC Form 4 filing on Tracefour is dated Mar 3, 2026.
What is JANNEY DANIEL's total buy and sell value in the current window?
Inside the rolling retention window, JANNEY DANIEL bought $0 and sold $19.4M based on SEC Form 4 filings.
What was JANNEY DANIEL's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 51,720 KRYS shares on 2026-02-24, worth $13.8M, per SEC Form 4 filings.